医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
5-羟基喹啉-8-甲腈 | 5-Hydroxy-quinoline-8-carbonitrile | 936345-80-1 | C10H6N2O |
|
5-羟基喹啉 | quinolin-5-ol | 578-67-6 | C9H7NO |
|
5-羟基咪唑并[1,2-a]嘧啶 | imidazolo<1,2-a>pyrimidine-5(1H)-one | 55662-68-5 | C6H5N3O |
|
5-羟基吲哚-3-甲醛 | 5-hydroxyindole-3-carbaldehyde | 3414-19-5 | C9H7NO2 |
|
5-羟基吲哚-3-乙酸 | 5-Hydroxyindole-3-acetic acid | 54-16-0 | C10H9NO3 |
|
5-羟基吲哚 | indol-5-ol | 1953-54-4 | C8H7NO |
|
5-羟基吡嗪-2-羧酸甲酯 | methyl 5-hydroxypyrazine-2-carboxylate | 13924-95-3 | C6H6N2O3 |
|
5-羟基吡嗪-2-羧酸 | 5-hydroxypyrazinoic acid | 34604-60-9 | C5H4N2O3 |
|
5-羟基吡啶-3,4-二羧酸-4-甲酯 | 5-hydroxypyridine-3,4-dicarboxylic acid 4-methyl ester | 243980-03-2 | C8H7NO5 |
|
5-羟基吡啶-2-磺酸 | 5-hydroxypyridine-2-sulfonic Acid | 139263-48-2 | C5H5NO4S |
|
5-羟基-7-氮杂吲哚 | 1H-pyrrolo[2,3-b]pyridin-5-ol | 98549-88-3 | C7H6N2O |
|
5-羟基-5,6,7,8-四氢喹啉 | 5,6,7,8-tetrahydroquinolin-5-ol | 194151-99-0 | C9H11NO |
|
5-羟基-4-甲氧甲基-6-甲基-3-吡啶甲醇 | ginkgotoxin | 1464-33-1 | C9H13NO3 |
|
5-羟基-4-甲氧基-2-硝基苯甲醛 | 3-hydroxy-4-methoxy-6-nitrobenzaldehyde | 58749-47-6 | C8H7NO5 |
|
5-羟基-4-甲基嘧啶 | 4-methyl-5-hydroxypyrimidine | 101257-87-8 | C5H6N2O |
|
5-羟基-4-正丙基-2-呋喃酮 | 5-hydroxy-4-propylfuran-2(5H)-one | 78920-10-2 | C7H10O3 |
|
5-羟基-4(1H)-嘧啶酮 | 5-hydroxypyrimidin-4(3H)-one | 15837-41-9 | C4H4N2O2 |
|
5-羟基-3-吡啶羧胺 | 5-hydroxypyridine-3-carboxamide | 101512-21-4 | C6H6N2O2 |
|
5-羟基-3-吡啶甲醛 | 5-hydroxynicotinaldehyde | 1060804-48-9 | C6H5NO2 |
|
5-羟基-3,4-二氢-2H-异喹啉-1-酮 | 5-hydroxy-3,4-dihydroisoquinolin-1(2H)-one | 56469-02-4 | C9H9NO2 |
|
5-羟基-3,4-二氢-2-喹啉酮 | 5-hydroxycarbostyril | 30389-33-4 | C9H9NO2 |
|
5-羟基-2-甲氧基嘧啶 | 2-methoxypyrimidin-5-ol | 91233-70-4 | C5H6N2O2 |
|
5-羟基-2-甲氧基吡啶 | 6-methoxypyridine-3-ol | 51834-97-0 | C6H7NO2 |
|
5-羟基-2-甲基吲哚 | 2-methyl-1H-indol-5-ol | 13314-85-7 | C9H9NO |
|
5-羟基-2-甲基-1,2,3,4-四氢异喹啉 | 5-Hydroxy-2-methyl-1,2,3,4-tetrahydroisoquinoline | 14097-42-8 | C10H13NO |
|
5-羟基-2-氧代-1,2-二氢吡啶-4-羧酸 | 5-Hydroxy-2-oxo-1,2-dihydropyridine-4-carboxylic acid | 132829-86-8 | C6H5NO4 |
|
5-羟基-2-吡啶羧酸 | 5-hydroxypicolinic acid | 15069-92-8 | C6H5NO3 |
|
5-羟基-2-吡啶甲醇 | 5-hydroxy-2-hydroxymethylpyridine | 40222-77-3 | C6H7NO2 |
|
5-羟基-2-吡啶甲酸甲酯 | methyl 5-hydroxypicolinate | 30766-12-2 | C7H7NO3 |
|
5-羟基-2(1h)-嘧啶酮 | 2,5-Dihydroxypyrimidin | 4874-29-7 | C4H4N2O2 |
|
5-羟基-2(1H)-喹啉酮 | NCI 134652 | 31570-97-5 | C9H7NO2 |
|
5-羟基-1-甲基咪唑啉-2,4-二酮 | 1-methyl-5-hydroxy-imidazoline-2,4-dione | 84210-26-4 | C4H6N2O3 |
|
5-羟基-1-甲基-3-三氟甲基-1H-吡唑 | 1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-ol | 122431-37-2 | C5H5F3N2O |
|
5-羟基-1,2,3,4-四氢异喹啉 | 1,2,3,4-tetrahydroisoquinolin-5-ol | 102877-50-9 | C9H11NO |
|
5-磺酸基间苯二甲酸 | 5-sulfoisophthalic acid | 22326-31-4 | C8H6O7S |
|
5-碘异喹啉 | 5-iodoisoquinoline | 58142-99-7 | C9H6IN |
|
5-碘尿嘧啶 | 5-Iodouracil | 696-07-1 | C4H3IN2O2 |
|
5-碘嘧啶 | 5-iodopyrimidine | 31462-58-5 | C4H3IN2 |
|
5-碘喹啉-8-醇 | 5-iodoquinolin-8-ol | 13207-63-1 | C9H6INO |
|
5-碘喹啉 | 5-iodoquinoline | 1006-50-4 | C9H6IN |
|
5-碘哒嗪-3(2H)-酮 | 5-iodopyridazin-3(2H)-one | 825633-94-1 | C4H3IN2O |
|
5-碘吲哚-2-酮 | 5-iodoindolin-2-one | 193354-13-1 | C8H6INO |
|
5-碘吲哚 | 5-iodo-1H-indole | 16066-91-4 | C8H6IN |
|
5-碘吡啶-3-醇 | 3-iodo-5-hydroxypyridine | 213765-61-8 | C5H4INO |
|
5-碘吡啶-3-羧酸 | 5-iodonicotinic acid | 15366-65-1 | C6H4INO2 |
|
5-碘吡啶-2-羧酸甲酯 | methyl 5-iodopicolinate | 41960-44-5 | C7H6INO2 |
|
5-碘吡啶-2-羧酸 | 5-Iodpicolinsaeure | 32046-43-8 | C6H4INO2 |
|
5-碘吡唑并[1,5-a]嘧啶 | 5-iodo-pyrazolo[1,5-a]pyrimidine | 705262-65-3 | C6H4IN3 |
|
5-碘-8-甲基喹啉 | 5-iodo-8-methylquinoline | 88474-17-3 | C10H8IN |
|
5-碘-7H-吡咯并[2,3-d]嘧啶-4-胺 | 5-iodo-7H-pyrrolo[2,3-d]pyrimidin-4-amine | 163622-50-2 | C6H5IN4 |
|